AURELIO-04: A PHASE 2, OPEN-LABEL, SINGLE-ARM, MULTICENTER STUDY TO DETERMINE THE EFFICACY AND SAFETY OF SOT101 IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH SELECTED ADVANCED SOLID TUMORS

被引：1
|
作者：
Champiat, Stephane [1 ]
Marabelle, Aurelien [1 ]
Davar, Diwakar [2 ]
Grell, Peter [3 ]
Ouali, Kaissa [1 ]
Patrikidou, Anna [1 ]
Schoenenberger, Andreu [4 ]
Jelinkova, Lenka Palova [4 ]
Adkins, Irena [4 ]
Tillmanns, Sascha [5 ]
Kiemle-Kallee, Joachim [5 ]
Sachse, Richard [5 ]
Garralda, Elena [6 ]
机构：
[1] Gustave Roussy, Villejuif, France
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Masaryk Mem Canc Inst, Brno, Czech Republic
[4] SOTIO Biotech AS, Prague, Czech Republic
[5] SOTIO Biotech AG, Basel, Switzerland
[6] Vall dHebron Inst Oncol, Barcelona, Spain
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0716
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
716
引用
收藏
页码：A749 / A749
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
    Shuichi Ito
    Yuya Nishiyama
    Kenkichi Sugiura
    Kazuaki Enya
    Clinical and Experimental Nephrology, 2022, 26 : 350 - 358
  • [32] Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study
    Zhang, Yi
    Zhou, Hu
    Duan, Minghui
    Gao, Sujun
    He, Guangsheng
    Jing, Hongmei
    Li, Junmin
    Ma, Liangming
    Zhu, Huanling
    Chang, Chunkang
    Du, Xin
    Hong, Mei
    Li, Xin
    Liu, Qingchi
    Wang, Wei
    Xu, Na
    Yang, Haiping
    Lu, Binhua
    Yin, Hewen
    Wu, Liqing
    Suo, Shanshan
    Zhao, Qingwei
    Xiao, Zhijian
    Jin, Jie
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, : 1588 - 1597
  • [33] Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
    Priscilla K. Brastianos
    Eudocia Quant Lee
    Justine V. Cohen
    Sara M. Tolaney
    Nancy U. Lin
    Nancy Wang
    Ugonma Chukwueke
    Michael D. White
    Naema Nayyar
    Albert Kim
    Christopher Alvarez-Breckenridge
    Ian Krop
    Maura Keeley Mahar
    Mia S. Bertalan
    Brian Shaw
    Joana L. Mora
    Nathaniel Goss
    Megha Subramanian
    Lakshmi Nayak
    Jorg Dietrich
    Deborah A. Forst
    Brian V. Nahed
    Tracy T. Batchelor
    Helen A. Shih
    Elizabeth R. Gerstner
    Beverly Moy
    Donald Lawrence
    Anita Giobbie-Hurder
    Scott L. Carter
    Kevin Oh
    Daniel P. Cahill
    Ryan J. Sullivan
    Nature Medicine, 2020, 26 : 1309 - 1309
  • [34] BGB-A317-212: A multicenter, open-label, phase II study to evaluate the efficacy and safety of tislelizumab in combination with lenvatinib in patients with selected solid tumors
    Liu, Yufei
    He, Zhisong
    Zhang, Mingjun
    Jiang, Shusuan
    Zhang, Dahong
    Feng, Miao
    Qu, Shenhong
    Ju, Wutong
    Wang, Ke
    Feng, Jifeng
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Avatrombopag for the treatment of thrombocytopenia induced by chemotherapy in patients with solid tumors: A multicenter, open-label, single-arm trial
    Cui, Yayun
    He, Yifu
    Hu, Changlu
    Tu, Congyin
    Huang, Jin
    Zhu, Xiaofeng
    Zang, Chunbao
    Ding, Kaiyang
    Zhan, Bihong
    Zhao, Yufei
    Qian, Liting
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [36] A FIRST-IN-HUMAN, MULTICENTER, PHASE 1/2, OPEN-LABEL STUDY OF XTX101 IN PATIENTS WITH ADVANCED SOLID TUMORS
    Powderly, John
    Norman, Teleen
    Duncan, Meghan
    Huber, Martin
    O'Neil, Jennifer
    Patel, Ekta
    Vandross, Andrae
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A549 - A549
  • [37] Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
    Tsuyoshi Matsumura
    Hiroya Hashimoto
    Masahiro Sekimizu
    Akiko M. Saito
    Yasufumi Motoyoshi
    Akinori Nakamura
    Satoshi Kuru
    Takayasu Fukudome
    Kazuhiko Segawa
    Toshiaki Takahashi
    Takuhisa Tamura
    Tetsuo Komori
    Chigusa Watanabe
    Masanori Asakura
    Koichi Kimura
    Yuko Iwata
    Orphanet Journal of Rare Diseases, 17
  • [38] Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
    Matsumura, Tsuyoshi
    Hashimoto, Hiroya
    Sekimizu, Masahiro
    Saito, Akiko M.
    Motoyoshi, Yasufumi
    Nakamura, Akinori
    Kuru, Satoshi
    Fukudome, Takayasu
    Segawa, Kazuhiko
    Takahashi, Toshiaki
    Tamura, Takuhisa
    Komori, Tetsuo
    Watanabe, Chigusa
    Asakura, Masanori
    Kimura, Koichi
    Iwata, Yuko
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [39] A PROSPECTIVE PHASE II, OPEN-LABEL, SINGLE-ARM, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF SEG101 (CRIZANLIZUMAB) IN SICKLE CELL DISEASE PATIENTS WITH PRIAPISM (SPARTAN)
    Burnett, A.
    El Rassi, F.
    Darbari, D.
    Paulose, J.
    Laine, D.
    Purkayastha, D.
    Kato, G.
    JOURNAL OF SEXUAL MEDICINE, 2020, 17 (01): : S43 - S43
  • [40] A single-arm, open-label, multicenter study of tranilast for advanced heart failure in patients with muscular dystrophy
    Matsumura, T.
    Hashimoto, H.
    Sekimizu, M.
    Saito, A.
    Asakura, M.
    Kimura, K.
    Iwata, Y.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S103 - S103
12345